课题基金 / 基金详情

REPLACEMENT THERAPY OF DENTAL CARIES

REPLACEMENT THERAPY OF DENTAL CARIES
龋齿的替代治疗
批准号:
3219091
负责人:
Jeffrey D. Hillman
金额:
$13.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1976
资助国家:
美国
项目状态:
已结题
起止时间:
1976-06-01 至 1989-08-31

项目摘要

项目成果

Jeffrey D. Hillman的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Replacement therapy has been shown to work successfully in rodents for the prevention of dental caries. This application describes studies designed to develop replacement therapy for the prevention of dental caries in humans. The purpose of Aims 1 and 2 is to further understand the physiology and ecological parameters of Streptococcus mutans in order to construct an effector strain that is both non-virulent and capable of efficiently colonizing the human oral cavity. These studies will involve accurate analysis of the fermentation patterns of wild-type and lactate dehydrogenase-deficient S. mutans, and identification of heritable changes that occur during prolonged colonization of the human oral cavity which help to adapt S. mutans to that environment. From the information obtained, idealized effector strains will be isolated. They will be tested in Aim 3, using gnotobiotic and conventional rat models, for their cariogenic potential. The ability of the effector strains to preemptively colonize the oral cavities of rodents, and displace indigenous strains of S. mutans will be tested in Aim 4. A strain of S. mutans that produces an unusually potent bacteriocin will serve as the starting strain for these studies. In Aim 5 the minimum infection regimen required to obtain high levels of colonization by this strain in humans will be examined in a clinical pilot study involving 3 subjects. Microbiological analysis of saliva and plaque from these subjects will be used to determine the effects of the effector strain on indigenous S. mutans populations and on the general plaque microflora. The bacteriocin produced by this strain of S. mutans is of interest as a topical anti-caries agent. In Aim 6, methods for its purification, sequencing, and in vitro synthesis are developed, using both conventional biochemical and recombinant DNA technology. Aim 7 involves studies to directly demonstrate the role of the bacteriocin an an ecological determinant. The bacteriocin will also be tested in a rodent model for its ability to serve as a topical anti-caries agent.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of Novel Genes Expressed in Bowel Cancer Using Change Mediated Ant
  • 批准号:
    7266598
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2007
  • 负责人:
    Jeffrey D. Hillman
  • 依托单位:
Genes of M. tuberculosis Induced During Human Infection
  • 批准号:
    6736413
  • 项目类别:
  • 资助金额:
    $10.0万
  • 财政年份:
    2004
  • 负责人:
    Jeffrey D. Hillman
  • 依托单位:
SMALL BIOEFFECTOR MOLECULES OF STREPTOCOCCUS MUTANS
  • 批准号:
    6176151
  • 项目类别:
  • 资助金额:
    $24.76万
  • 财政年份:
    1998
  • 负责人:
    Jeffrey D. Hillman
  • 依托单位:
SMALL BIOEFFECTOR MOLECULES OF STREPTOCOCCUS MUTANS
  • 批准号:
    2631568
  • 项目类别:
  • 资助金额:
    $33.93万
  • 财政年份:
    1998
  • 负责人:
    Jeffrey D. Hillman
  • 依托单位:
海外基金